These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
670 related items for PubMed ID: 2017225
1. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F, Freund M, Meusers P, Salama A, Heimpel H. N Engl J Med; 1991 May 09; 324(19):1297-304. PubMed ID: 2017225 [Abstract] [Full Text] [Related]
2. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study. Locasciulli A, Bruno B, Rambaldi A, Saracco P, Dufour C, Finelli C, Sica S, Varotto S, Arcese W, Locatelli F, Soligo D, Bacigalupo A, GITMO prospective randomized study. Haematologica; 2004 Sep 09; 89(9):1054-61. PubMed ID: 15377466 [Abstract] [Full Text] [Related]
3. Treatment of acquired severe aplastic anemia with antilymphocyte globulin, cyclosporin A, methyprednisolone, and granulocyte colony-stimulating factor. Dinçol G, Aktan M, Diz-Küçükkaya R, Yavuz S, Nalçaci M, Oztürk S, Palanduz S, Doğan O, Ağan M. Am J Hematol; 2007 Sep 09; 82(9):783-6. PubMed ID: 17506070 [Abstract] [Full Text] [Related]
10. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study. Shin SH, Yoon JH, Yahng SA, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Kim HJ, Cho SG, Kim DW, Min WS, Park CW, Lee JW. Ann Hematol; 2013 Jun 09; 92(6):817-24. PubMed ID: 23318980 [Abstract] [Full Text] [Related]
12. [Cyclosporin A in severe aplastic anemia in children]. Lackner H, Urban C, Kaulfersch W, Slavc I, Gamillscheg A, Hauer C. Padiatr Padol; 1989 Jun 09; 24(4):313-20. PubMed ID: 2616176 [Abstract] [Full Text] [Related]
14. [Antilymphocyte globulin in the treatment of aplastic anemia]. Malesević M, Tukić L, Stamatović D, Trajković Z, Krstić C. Med Pregl; 1993 Jun 09; 46(7-8):291-5. PubMed ID: 7968829 [Abstract] [Full Text] [Related]
15. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group. Führer M, Burdach S, Ebell W, Gadner H, Haas R, Harbott J, Janka-Schaub G, Klingebiel T, Kremens B, Niemeyer C, Rampf U, Reiter A, Ritter J, Schulz A, Walther U, Zeidler C, Bender-Götze C. Klin Padiatr; 1998 Jun 09; 210(4):173-9. PubMed ID: 9743949 [Abstract] [Full Text] [Related]
16. The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia. Jiang S, Wang Y, Shi W, Shao Y, Qiao X, Lin J, Kuang H, Xie X. Pediatr Hematol Oncol; 2009 Jun 09; 26(5):313-20. PubMed ID: 19579077 [Abstract] [Full Text] [Related]
17. Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. Champlin R, Ho W, Gale RP. N Engl J Med; 1983 Jan 20; 308(3):113-8. PubMed ID: 6336819 [Abstract] [Full Text] [Related]